Genetic and environmental factors are involved in immediate hypersensitivity reactions to ß-lactam antibiotics. Several genes have been associated with immediate hypersensitivity reactions to ß-lactams, including those encoding cytokines and receptors involved in the synthesis of IgE (FCER1), as well as signal transduction proteins and products released by mast cells. Nevertheless, analysis of publications reporting on genetic association studies in patients allergic to ß-lactams reveals that most were performed in 3 main populations and, in most cases, by the same groups of investigators, who progressively increased the population sample in successive studies. Most of the publications reported a series of concerns, namely, the diagnosis was not always based on skin or challenge tests, tolerance to ß-lactams in controls was not proved, and atopy was not taken into account.
Genetic and environmental factors are involved in immediate hypersensitivity reactions to ß-lactam antibiotics. Several genes have been associated with immediate hypersensitivity reactions to ß-lactams, including those encoding cytokines and receptors involved in the synthesis of IgE (FCER1), as well as signal transduction proteins and products released by mast cells. Nevertheless, analysis of publications reporting on genetic association studies in patients allergic to ß-lactams reveals that most were performed in 3 main populations and, in most cases, by the same groups of investigators, who progressively increased the population sample in successive studies. Most of the publications reported a series of concerns, namely, the diagnosis was not always based on skin or challenge tests, tolerance to ß-lactams in controls was not proved, and atopy was not taken into account.
The first group of studies was conducted in a Chinese population [1] [2] [3] , among whom some patients were diagnosed based on the clinical history, and immediate and nonimmediate reactions were mixed. The number of patients and controls increased with the successive studies, although samples were not generally large. Controls did not usually have proven tolerance to penicillin but were included because they had a negative history of allergy to ß-lactams, negative questionnaire result, or negative specific IgE or skin test results. The In short, the review of these studies suggests that larger populations are needed, diagnostic criteria must be homogeneous and not based only on the clinical history, tolerance to ß-lactams should be verified in control groups, different reactions should be analyzed separately, and atopy should be considered as a possible confounding factor.
We evaluated whether atopy could be a confounding factor in genetic studies on ß-lactam allergy. Following the ENDA protocol, we evaluated 98 patients diagnosed with immediate hypersensitivity to ß-lactams and 104 controls who had a negative result and tolerated a full dose of a ß-lactam (see the methods section in Supplementary material). Skin tests with a locally adapted battery of common aeroallergens were performed in both patients and controls. Atopy was defined as the presence of at least 1 positive skin test result with allergens from the test series. No statistically significant differences were observed between patients and controls regarding age, sex, atopy, or total IgE levels ( Supplementary table 1 ).
By analyzing 22 polymorphisms in patients with ß-lactam hypersensitivity compared with controls, the only statistically significant differences identified were for the TGFB1 singlenucleotide polymorphism (SNP) c25, with the C allele at codon 25 being significantly more frequent in ß-lactampositive patients (11.8%) than in controls (4.5%) (P=.029) (see Supplementary material). When patients were classified according to atopy, irrespective of ß-lactam sensitization, statistically significant differences were found between controls and patients for the following SNPs: IL1R pst1 +1970, IFNG +874, and IL4 -33 (Table) . To confirm whether these differences were due to ß-lactam hypersensitivity or to atopy, we compared atopic and nonatopic patients with ß-lactam allergy and found the same statistically significant differences mentioned above. In addition, we found an association with the SNP IL4RA +1902 ( Supplementary table 3 ). No differences were found between ß-lactam-allergic and ß-lactam-tolerant patients when only nonatopic patients were evaluated, irrespective of ß-lactam sensitization.
In summary, in our study, in which proven tolerance to ß-lactams and atopic status were taken into account, we detected statistically significant differences between atopic and nonatopic ß-lactam-allergic patients, as well as between atopic ß-lactam-allergic patients and controls, although not between nonatopic patients. Therefore, we suggest that atopy percentages of atopy were not taken into consideration in patients or controls. The genes involved were IL4, IL13, IL4RA, IFNR1, IL18, and STAT6.
The second group of studies were conducted in a Korean population. In one study [4] , types of reaction (urticaria, angioedema, maculopapular rash, and exudative erythema) and antibiotics (eg, ß-lactams, quinolones) were assessed using a database of adverse drug reactions; however, the controls were from a previous study on the PGE2 receptor, and their characteristics were not described. Another study [5] evaluated patients occupationally exposed to cephalosporins and unexposed nonatopic controls with negative skin test results to 3 frequently prescribed cephalosporins. However, only 4 patients reported work-related symptoms, and only 1 patient had positive skin test results and symptoms upon exposure to a cephalosporin. Although atopy was considered in 1 of the studies, it was not taken into account in the genetic analyses. The genes involved were FCERB1 and CD40.
The third group of studies were conducted in European populations, initially in Italian patients, who were evaluated in collaboration with French researchers [6, 7] . Later, a Spanish population was analyzed [8] . In the first of the studies [6] , patients were diagnosed according to whether they had a clinical history compatible with an immediate reaction and positive skin test or specific IgE results, while controls were selected from age-matched volunteers in a query from an allergist on the basis of absence of drug reactions (tolerance was not confirmed). Although atopy was not considered, total IgE levels were higher in patients than in controls. In the study involving Italian and Spanish patients [8] , immediate and delayed reactions were evaluated simultaneously. Patients were diagnosed according to the recommendations of the European Network for Drug Allergy (ENDA); however, the controls were from a preventive care clinic. In these studies, total IgE levels were higher in patients than in controls. In another Spanish study [9] , patients were diagnosed based on positive results in skin or controlled drug exposure tests, and controls were selected on the basis of not having reported a history of ß-lactam allergy. A significantly higher percentage of atopy was also observed in ß-lactam-allergic patients, according to total IgE levels and specific IgE to prevalent allergens, which were significantly more frequent than in controls. The genes involved were IL4RA, IL13, TNFA, and NOD. Mastocytosis is a heterogeneous disorder characterized by the proliferation and accumulation of mast cells (MCs) in the skin, bone marrow, and other tissues [1] . Owing to massive MC activation and release of mediators, patients with mastocytosis may experience systemic symptoms, including hypotension and shock, flushing, headache, abdominal pain, and diarrhea. Serum baseline tryptase correlates with the total MC count and burden and is increased in many patients. In mastocytosis, MC can be activated by various stimuli, including hymenoptera venom, through an IgE-mediated mechanism [2] . There are several reports on patients with systemic mastocytosis (SM) and a history of severe sting reactions, but with negative venom-specific IgE and skin test results [3] . In such cases, other diagnostic methods, such as the basophil activation test (BAT), can prove useful [4] . Reports about the usefulness of BAT in patients with negative specific IgE (sIgE) results show varying results. Some studies find that BAT does not provide useful information in this kind of patient [5, 6] , while other papers report the opposite [7, 8] . Interestingly, different methods for identifying basophils were used in the studies, and negative results were obtained in those using chemokine CC receptor type 3 (CCR3) [5, 6] , whereas positive results were obtained in those using the IL3 receptor (CD123) in conjunction with HLA-DR [7] or CD45 and IgE [8] .
We discuss the usefulness of BAT in 2 patients with systemic reactions after wasp sting and mastocytosis.
We studied 2 men aged 53 and 64 years (patient 1 and patient 2, respectively) with systemic reactions after wasp sting. Patient 1 presented dizziness, vomiting, dyspnea, and loss of consciousness 25 minutes after the sting, and patient 2 experienced flushing and loss of consciousness 10 minutes after the sting. Neither experienced cutaneous symptoms. Both had high tryptase values (>20 μg/mL) (Table) 1 month after the reactions.
is a confounding factor that is overrepresented in ß-lactamallergic patients and that the previously described associations could have been due to atopy.
